This is the logo of the provider
AASLD 2025 7 - 10 November 2025

Semaglutide is effective in improving liver fibrosis across a diverse population: ESSENCE subgroup analysis

Authors :

Mary E. Rinella1; Manal F. Abdelmalek2; Elisabetta Bugianesi3; Laurent Castera4,5; Mette Skalshøi Kjær6; Jacob George7; Wah Kheong Chan8; Niels Krarup6; Michelle T. Long6; Philip N. Newsome9,10; Cláudia P. Oliveira11; Georgios Papatheodoridis12; Ahsan Shoeb6; Salvatore Petta13; Michael Roden14,15,16; Arun J. Sanyal17; Yusuf Yilmaz18; Vlad Ratziu19; on behalf of the ESSENCE Trial Group

Affiliations
View Details Hide Details
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Download poster (.pdf)
Keywords
MASH
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)